Clinical Trials Directory

Trials / Recruiting

RecruitingNCT02391051

Focal Brachytherapy in Patients With Selected "Low-risk" Prostate Cancer - a Phase-II-trial

Status
Recruiting
Phase
Phase 2
Study type
Interventional
Enrollment
50 (estimated)
Sponsor
University of Erlangen-Nürnberg Medical School · Academic / Other
Sex
Male
Age
18 Years
Healthy volunteers
Not accepted

Summary

This trial examines the feasibility and toxicity of focal brachytherapy in patients with low-risk prostate cancer.

Detailed description

Patients with low-risk prostate cancer will receive HDR-Brachytherapy: 2 x 13,5 Gy.

Conditions

Interventions

TypeNameDescription
RADIATIONHDR-BrachytherapyHDR-Brachytherapy 2x 13,5 Gy

Timeline

Start date
2014-10-01
Primary completion
2019-12-01
Completion
2029-12-01
First posted
2015-03-18
Last updated
2017-08-11

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT02391051. Inclusion in this directory is not an endorsement.

Focal Brachytherapy in Patients With Selected "Low-risk" Prostate Cancer - a Phase-II-trial (NCT02391051) · Clinical Trials Directory